中国科学院昆明植物研究所
location
当前位置:首页 > 植化重点实验室 > 李艳研究组 > 发表论文
left
李艳研究组
发表论文

Biflavone Ginkgetin, a Novel Wnt Inhibitor, Suppresses the Growth of Medulloblastoma

文章来源:  |  发布时间:2018-06-27  |  作者:  |  浏览次数:  |  【打印】 【关闭

 

Abstract

  

  

  Medulloblastoma (MB) is a form of malignant brain tumor that predominantly arises in infants and children, of which approximately 25 % is due to upregulation of canonical Wnt pathway with mainly mutations in CTNNB1. Therefore, Wnt inhibitors could offer rational therapeutic strategies and chemoprevention for this malignant cancer. In our present study, we undertook a screening for antagonists of Wnt signaling from 600 natural compounds, and identified Ginkgetin, a biflavone isolated from Cephalotaxus fortunei var. alpina. Ginkgetin inhibited Wnt pathway with an IC50 value around 5.92 μM and structure–activity relationship analysis suggested the methoxy group in Ginkgetin as a functional group. Biflavone Ginkgetin showed obvious cytotoxicity in Daoy and D283 MB cells. Cell cycle analysis by flow cytometry showed that Ginkgetin induced efficiently G2/M phase arrest in Daoy cells. Further mechanism studies showed that Ginkgetin reduced the expression of Wnt target genes, including Axin2, cyclinD1 and survivin in MB cells. The phosphorylation level of β-catenin also decreased in a time- and concentration-dependent manner. Collectively, our data suggest that Ginkgetin is a novel inhibitor of Wnt signaling, and as such warrants further exploration as a promising anti-medulloblastoma candidate.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402583/


中国科学院昆明植物研究所

版权所有 Copyright © 2002-2016 中科院昆明植物研究所,All Rights Reserved 【滇ICP备05000394号
地址:中国云南省昆明市蓝黑路132号  邮政编码:650201    点击这里联系我们